Loading clinical trials...
Loading clinical trials...
Drainage of Subglottic Secretions and Prevention of Ventilator-associated Pneumonia in Intensive carE Units: Medico-Economic Study With a Randomized clusTer and crossovER Design: DEMETER Study
In France, despite the implementation of bundles to prevent Ventilator-Associated Pneumonia (VAP) in the last decades, the VAP incidence remains high above 10 per cent. In the last american recommendations of VAP prevention, the drainage of subglottic secretions (SSD) has been notified among the "basic practices" to prevent VAP. Nevertheless, the diffusion of SSD in ICUs remains limited. This situation is largely due to the initial overcost of the specific endotracheal tubes allowing SSD and to the unavailability of these devices in medical units in which patients are intubated before the ICU admission. So, this pragmatical cluster randomized and cross-over study evaluates the medico-economic impact of the subglottic secretions drainage in addition to VAP prevention bundles in ICU.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
CHU André Vésale ,
Montigny-le-Tilleul, Belgium
CH Angoulème
Angoulème, France
CH Annecy Genevois
Annecy, France
Centre Hospitalier Victor Dupouy
Argenteuil, France
Centre Hospitalier Intercommunal des Portes de l'Oise
Beaumont-sur-Oise, France
CHU Dijon
Dijon, France
CHD Vendee
La Roche-sur-Yon, France
CH Docteur Schaffner
Lens, France
Centre Hospitalier François Quesnay
Mantes-la-Jolie, France
CHU marseilles, Hôpital Nord
Marseilels, France
Start Date
November 5, 2015
Primary Completion Date
November 22, 2018
Completion Date
November 22, 2018
Last Updated
January 15, 2019
2,577
ACTUAL participants
Endotracheal tubes not allowing SSD
DEVICE
Endotracheal tubes allowing SSD
DEVICE
Lead Sponsor
Centre Hospitalier Departemental Vendee
Collaborators
NCT07013032
NCT07149909
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06066736